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Abstract  Carcinomatous  mastitis  is  a  severe  form  of  breast  cancer  and  its  diagnosis  is  essen-
tially clinical  and  histological.  The  ﬁrst  examination  to  perform  is  still  mammography,  not  only
to provide  evidence  supporting  this  diagnosis  but  also  to  search  for  a  primary  intramammary
lesion and  assess  local/regional  spread.  It  is  essential  to  study  the  contralateral  breast  for
bilaterality.  Ultrasound  also  provides  evidence  supporting  inﬂammation,  but  appears  to  be  bet-
ter for  detecting  masses  and  analysing  lymph  node  areas.  The  role  of  MRI  is  debatable,  both
from a  diagnostic  point  of  view  and  for  monitoring  during  treatment,  and  should  be  reserved
for selected  cases.  An  optimal,  initial  radiological  assessment  will  enable  the  patient  to  be
monitored  during  neoadjuvant  chemotherapy.
© 2011  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Inﬂammatory  breast  cancer,  also  known  as  carcinomatous  mastitis,  T4d,  or  PEV  2 or  3,  is
the  only  real  therapeutic  emergency  in  breast  oncology,  given  the  high  risk  of  metastasis,
the  reason  for  the  most  unfavourable  prognosis  of  all  breast  cancers  [1].  It  must  conse-
quently  be  diagnosed  rapidly,  and  imaging  examinations  must  in  no  case  delay  therapeutic
management.  Let  us  remember  that  the  diagnosis  of  this  particular  form  of  breast  cancer
is  essentially  clinical  (Fig.  1)  and  histological  [2].  Imaging  nevertheless  has  its  place  in  the
management  of  this  breast  disease,  particularly  to  exclude  differential  diagnoses,  charac-
terise  intramammary  lesions  particularly  so  as  to  guide  taking  biopsies,  and  for  assessing
local/regional  spread.  Moreover  imaging  plays  an  important  role  in  searching  for  remote
metastases  (a  point  that  will  not  be  covered  here),  and  in  evaluating  the  response  to
treatment  [3,4].
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Figure 1. Clinical appearance of inﬂammatory breast cancer
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parasternal  nodes  (Fig.  4).  According  to  Yang  et  al.  [10],ssociating periareolar erythema with skin thickening, an increase
n breast volume and nipple retraction.
ammography
 mammogram  is  obviously  still  the  ﬁrst  examination  to
e  performed  for  a  patient  with  breast  inﬂammation.  In  a
umber  of  cases  it  will  provide  essential  information  about
he  breast  concerned  but  also  and  above  all  about  the
ontralateral  breast.  Indeed,  even  if  the  rate  of  bilaterality
s  still  being  debated,  the  rate  of  cancer  in  the  contralateral
reast  is  in  the  order  of  0.9  to  4%  [5].
Obtaining  a  mammogram  in  a  case  of  acute  breast
nﬂammation  can  be  difﬁcult,  even  impossible,  considering
he  pain  caused  and  the  difﬁculties  of  compression.  In
he  rare  situations  where  it  is  technically  impossible,  a
ammogram  at  least  of  the  contralateral  breast  must  be
btained.
The  abnormal  mammogram  signs  in  this  context  have
een  extensively  described  in  the  literature  (Fig.  2),  the
ost  common  being  thickening  of  the  skin,  found  in  84%  of
ases  in  Günhan-Bilgen’s  study  [5].  This  thickening,  often
ore  marked  where  breast  volume  is  small,  would  seem  to
redominate  initially  in  the  inferior  areolar  region,  before
apidly  extending  to  the  entire  skin  covering.  As  with  most
f  the  phenomena  visible  to  imaging,  it  seems  to  be  linked
o  tumoural  obstruction  of  the  lymphatics,  causing  defec-
ive  drainage,  particularly  of  the  skin  [6].  The  second  most
ommon  sign  is  trabecular  thickening,  found  in  81%  of  cases
nd  which  has  the  same  histological  origin  as  the  thick-
ning  of  the  skin.  Moreover,  there  is  frequently  an  overall
ncrease  in  the  density  of  the  breast  related  to  intramam-
ary  oedema;  this  increase  in  density  adversely  affects
ammogram  reading,  in  particular,  searching  for  subjacent
asses.  This  overall  increase  in  density  is  seen  in  93.5%  of
ases  in  Tardivon’s  study  [7].  On  the  other  hand,  contrary
o  the  observations  of  Dershaw  in  his  study  from  1994  [8],
ccording  to  Günhan-Bilgen’s  study  an  intramammary  mass
s  clearly  found  in  just  16%  of  cases,  the  lesions  usually  only
eing  seen  as  focal  asymmetric  density  (61%  of  cases).  Archi-
ectural  distortions  are  rarer  and  the  overall  increase  in
reast  density  remains  isolated  in  37%  of  cases.  Microcal-
iﬁcations  are  seen  in  approximately  56%  of  cases,  which
learly  distinguishes  this  condition  from  locally  advanced
ancer,  much  more  frequently  associated  with  the  lesions  of
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xtensive  intraductal  carcinoma.  The  literature  contains
 wide  variation  as  regards  the  percentage  of  masses
nd  microcalciﬁcations  identiﬁed  in  this  inﬂammatory  con-
ext,  with  some  old  studies  not  distinguishing  between
rimary  inﬂammatory  cancer  and  the  secondary  inﬂam-
ation  of  advanced  cancer,  which  much  more  often
resents  a  mass  and  calciﬁcations.  The  appearance  of
he  microcalciﬁcations  of  inﬂammatory  cancer  can  be
ery  variable,  with  diffuse  distribution  of  benign  micro-
alciﬁcations  in  about  10%  of  cases.  Nevertheless,  when
hey  are  present,  they  are  usually  ACR4  or  even  5  [9].
nother  sign  frequently  observed  is  nipple  retraction,  vis-
ble  in  43%  of  cases  on  the  mammogram  [5],  which  totally
grees  with  the  rate  of  nipple  retraction  found  clinically.
inally,  in  24%  of  cases  the  mammogram  shows  axillary
denomegaly.
It should  be  noted  that  the  arrival  of  the  digital  mam-
ogram  has  probably  considerably  improved  analysis  of  the
ifferent  signs,  which  is  partly  due  to  better  visualisation  of
he  skin  envelope  of  the  breast  [4].
However,  and  according  to  Yang,  mammography  is  still
he  least  sensitive  technique  for  either  looking  for  an
ntramammary  lesion  or  for  detecting  any  multifocal  or  mul-
icentric  lesions  [10].
ltrasonography
hile  the  usefulness  of  ultrasound  in  breast  oncology  often
mounts  to  searching  for  biopsy  targets,  several  studies
ave  shown  that  a  detailed  bilateral  ultrasound  examina-
ion  including  the  lymph  node  areas  can  provide  additional
nformation  (Fig.  3).  A  high  frequency  probe  study  of  the
kin  itself  can  authenticate  skin  thickening  in  95%  of  cases,
 higher  result  than  the  sensitivity  of  mammography  can
rovide  [6].  This  can  be  vital,  particularly  when  the  mam-
ogram  is  considered  to  be  normal  or  when  a  mammogram  is
ot  possible.  While  some  studies  have  attempted  to  deter-
ine  the  normal  thickness  of  the  skin  [5],  in  the  end  it  is
he  thickness  of  the  skin  of  the  contralateral  breast,  which
sually  serves  as  a  reference.  The  second  essential  ultra-
ound  sign  is  of  an  overall  increase  in  the  echogenicity  of
he  breast  parenchyma,  related  to  the  oedema  and  the
hickened  Cooper’s  ligaments.  These  two  signs  are  found  in
6%  of  cases  of  inﬂammatory  cancer,  according  to  Günhan-
ilgen.  Of  course,  ultrasound  can  detect  masses  and  does
o  in  80%  of  cases,  the  lesions  being  sometimes  multifocal
nd  sometimes  multicentric.  The  rates  of  multifocality  and
ulticentricity  found  with  ultrasound  vary  widely  in  the  lit-
rature,  ranging  from  8%  for  Günhan-Bilgen  [5]  to  62%  for
ang  et  al.  [10]. In  certain  situations,  while  no  real  mass  is
dentiﬁed,  isolated  areas  of  attenuation  may  be  seen,  which
e  must  be  able  to  identify  and  biopsy  [5].  Other  less  deci-
ive  signs  may  be  seen,  such  as  dilatation  of  the  vessels  and
he  lymphatics  in  68%  of  cases,  or  pectoral  involvement.
astly,  an  essential  item  of  information  provided  by  ultra-
ound  is  very  good  analysis  of  the  lymph  node  areas,  not
nly  the  axillary  but  also  the  supra  and  sub-clavicular  orhere  seems  to  be  axillary  node  involvement  (an  increase  in
he  volume  of  the  nodes,  a  very  hypoechoic  appearance,  the
oss  of  fatty  hilum)  seen  with  ultrasound  in  93%  of  cases,  and
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Figure 2. Mammographic appearance of inﬂammatory breast cancer. a and b: MLO (a) and CC (b) incidence showing circumferential skin
thickening, trabecular thickening, an overall increase in the density of the breast, and several images of poorly deﬁned masses including a
superior medial mass (with coil). Nipple retraction can also be seen; c, d and e: MLO (c), and CC (d) incidence and enlarged CC image (e) of
another patient showing predominant periareolar skin thickening, with an overall increase in the density of the breast without a very clear
mass. On the magniﬁcation view (e) diffuse polymorphic microcalciﬁcations can be seen.
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tin  the  other  areas  mentioned  in  50%  of  cases.  Obviously  this
ultrasound  detection  is  more  sensitive  than  clinical  examina-
tion,  which  is  said  to  detect  lymph  node  involvement  only  in
68%  of  cases  [5].  Pretherapeutic  detection  of  these  instances
of  adenomegaly,  in  tandem  with  needle  biopsies,  can  of
course  provide  the  clinician  with  essential  information  for
the  initial  staging  of  the  breast  pathology  and  for  envisaging
appropriate  treatment,  particularly  as  regards  the  extent  of
post-treatment  radiotherapy.  Finally,  detailed  pretherapeu-
tic  ultrasound  analysis  will  serve  as  a  reference  for  later  per
and  post-chemotherapy  checks.
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he  following  chapter,  by  Cédric  de  Bazelaire’s  team,  specif-
cally  concerns  the  role  of  mammary  MRI.  The  signs  of  inﬂam-
atory  breast  cancer,  which  are  now  well  known  [11,12],
how  up  in  perfect  detail  (Fig.  5).  It  should  be  remembered
hat  even  if  MRI  is  recognised  as  being  the  most  sensitive
echnique  for  detecting  intramammary  lesions  and  looking
or  multifocality,  its  role  is  widely  disputed.  The  useful-
ess  of  in-depth  detection  of  possible  multifocality  is  indeed
ebatable,  given  the  ﬁnal  treatment,  which  generally
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Figure 3. Ultrasound appearance of the inﬂamed breast. a: Marked skin thickening with overall hyperechogenicity of the breast and a
voluminous deep spiculated mass; b: Poorly deﬁned attenuated area associated with skin thickening.
Figure 4. Axillary ultrasound. a: lymph node with benign appearance retaining a ﬁne cortex and an echogenic hilum; b: suspect lymph
node showing irregular eccentric thickening of the cortex while the fatty hilum is conserved; c: very suspect lymph node, of increased
thickness, with very thick cortex and virtual disappearance of the fatty hilum; d: Round, totally hypoechoic lymph node with metastatic
appearance.
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Figure 5. MRI appearance of the inﬂamed breast (a, c, and e: dynamic T1 after injection of gadolinium and subtraction at 3 minutes. b,
d and f: T2). a, b: Skin thickening in T2 hypersignal of the left breast, with punctiform enhancement. Diffuse intramammary oedema and
non-mass enhancement of the breast with micronodular appearance; c, d: skin thickening of the right breast in T2 hypersignal associated
with subcutaneous vessel hypertrophy and heterogeneous, reticular, diffuse non-mass enhancement of the breast. Intra-mammary oedema
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bin T2 and right axillary adenomegaly; e, f: increase in left breast vol
Diffuse non-mass enhancement and deep necrotic mass from the 
lymph nodes probably involved.
consists  of  a  total  mastectomy  [13]. In  this  situation,  its  use
can  only  be  logically  justiﬁed  for  looking  for  bilaterality.Therapeutic monitoring
In  the  large  majority  of  current  reference  documents,
the  standard  treatment  for  inﬂammatory  breast  cancer  is
o
o
p
fand in skin thickness associated with diffuse oedema of the breast.
 of the medial quadrants invading the pectoral. Left parasternal
eoadjuvant  chemotherapy  followed  by  total  mastectomy
ith  axillary  lymph  node  dissection  and  irradiation  [13]. In
hese  conditions,  the  extent  of  the  residual  lesions  seen
y  imaging  is  after  all  of  little  importance  in  the  choice
f  ﬁnal  surgical  treatment,  so  that  assessment  at  the  end
f  the  chemotherapy  is  less  important  than  in  the  case,  in
articular,  of  a  plan  for  conservative  management  (apart
rom  in  an  inﬂammatory  context)  [14].
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Nevertheless,  per-  and  post-chemotherapy  monitoring  is
f  course  undertaken,  if  only  to  assess  the  response  to  the
reatment,  and  possibly  change  the  therapy  if  there  is  insuf-
cient  response  or  progression.  In  this  context,  a  complete
reast  ultrasound  examination  is  generally  performed  at
he  end  of  chemotherapy  with  an  intermediate  assessment,
ften  using  ultrasound,  made  halfway  through  the  treat-
ent.  Clinical  monitoring  is  naturally  essential  in  the  case  of
n  inﬂammatory  carcinoma:  the  slightest  clinical  doubt  con-
erning  the  response  during  treatment  should  lead  to  earlier
adiological  evaluation.
As  far  as  MRI  is  concerned,  although  its  usefulness  in
onitoring  during  neoadjuvant  chemotherapy  has  been
idely  conﬁrmed,  its  indication  should  be  considered  case
y  case,  since  certain  indications  have  been  retained  for
maging,  for  example  in  the  context  of  prospective  stud-
es  evaluating  new  therapeutic  agents.  On  the  other  hand,
ome  studies  predict  the  possibility  of  early  evaluation  of
he  therapeutic  response  by  MRI  using  innovative  tech-
iques  (diffusion,  perfusion,  spectroscopy,  etc.).  Additional
arge-scale  studies  will  nevertheless  be  needed  before  these
echniques  are  routinely  used.
ifferential diagnosis
here  are  a  great  number  of  differential  diagnoses  for
nﬂammatory  cancer:  at  the  forefront  is  acute  infectious
astitis,  which  is  discussed  in  detail  in  the  previous  chap-
er.  While  in  a  certain  number  of  cases  the  clinical  picture
nd  history  are  enough  to  differentiate  these  diseases  from
nﬂammatory  breast  cancer,  this  differential  diagnosis  often
oses  major  problems.  Kamal  et  al.  [15]  attempted  to
etermine  the  infectious,  non-infectious  or  carcinomatous
ature  of  197  cases  of  breast  inﬂammation  from  mam-
ograms  and  ultrasound  scans.  Certain  ultrasound  signs
learly  indicate  an  infectious  pathology  (the  presence  of
oorly  circumscribed  collections,  or  an  abscess),  while
thers  rather  support  malignancy  (extensive  skin  thickening
nd  adenomegaly),  which  seems  to  agree  with  the  ultra-
ound  signs  described  above.  The  mammogram,  on  the  other
and,  seems  to  be  less  discriminating,  the  presence  of
etro-areolar  duct  ectasia  indicating  more  a  benign  nature,
hereas  diffuse  skin  thickening  and  an  increase  in  breast
ensity  seem  to  be  more  indicative  of  an  inﬂammatory
ancer.  According  to  the  study  by  Renz  et  al.,  the  MRI  mor-
hological  criteria  as  deﬁned  in  the  BI-RADS  lexicon  are
uite  insufﬁcient  for  distinguishing  between  the  two  con-
itions.  Certain  dynamic  criteria  could  provide  diagnostic
ssistance,  even  if  there  is  considerable  overlap,  particu-
arly  between  the  types  of  enhancement  curves  [16].
Post-traumatic,  surgical  and  radiation  treatment  are
ften  the  cause  of  a  real  inﬂammatory  picture,  even  if  the
ontext  very  often  gives  a  pointer  to  the  diagnosis.  Never-
heless,  considering  the  seriousness  of  inﬂammatory  breast
ancer,  and  while  a  short  waiting  period  can  be  tolerated,
oubt  should  often  lead  rapidly  to  a  complete  radiological
ssessment,  looking  for  the  signs  described  above.  These
adiological  examinations  must  be  interpreted  with  cau-
ion,  since  visualising,  for  example,  mammogram  images
voking  cytosteatonecrosis  obviously  does  not  exclude  adja-
ent  evolving  recurrence  in  an  inﬂammatory  form.  In  theseJ.-P.  Alunni
onditions,  it  should  be  widespread  practice  to  take  samples
or  histology.
An  often-difﬁcult  differential  diagnosis  is  that  of  locally
dvanced,  often  neglected,  breast  carcinoma  manifesting
econdarily  through  inﬂammation.  The  absence,  in  the  past,
f  differentiation  between  these  two  very  distinct  types  of
reast  pathology  has  probably  led  to  many  cases  of  confu-
ion  in  older  studies.  The  clinical  history  and  examination
enerally  enables  a  distinction  to  be  made  between  these
wo  types  of  lesion,  which  are  quite  different  clinico-
athological  entities  [17]. Nevertheless,  when  the  patient’s
nswers  to  questions  do  not  seem  to  be  reliable,  decisive
orphological  aspects  can  be  used,  such  as  the  presence  on
he  mammogram  of  voluminous  masses  and  extensive  calci-
cations.  Many  authors  have  also  looked  into  the  differential
haracteristics  of  these  two  conditions  with  MRI  [18,19],
hich  has  identiﬁed  very  different  imaging  characteristics
or  these  two  diseases  that  have  often  been  confused  in  the
ast.
TAKE-HOME  MESSAGES
Mammography
• The  most  frequent  signs  of  inﬂammatory  cancer  are
skin  thickening,  trabecular  thickening  and  an  overall
increase  in  the  density  of  the  breast.
• Masses,  distortions  and  microcalciﬁcations  are  less
common  in  carcinomatous  mastitis  than  in  locally
advanced  breast  cancer.
• Mammography  is  the  least  sensitive  technique  for
detecting  intramammary  masses  in  an  inﬂammatory
context.
Ultrasonography
• Inﬂammatory  cancer  is  seen  as  thickening  of  the
skin  and  an  increase  in  echogenicity  of  the  breast
parenchyma.
• Ultrasound  can  detect  breast  masses  and  search
for  multifocality  with  greater  sensitivity  than
mammography.
• The  analysis  of  lymph  node  areas  is  essential,
considering  the  frequency  in  particular  of  supra  and
sub-clavicular  involvement.
MRI
• The usefulness  of  MRI  is  much  debated  both  for
pretherapeutic  assessment  and  for  monitoring  during
chemotherapy.
• The  differential  diagnosis  with  infectious  mastitis
may  also  be  difﬁcult.
Therapeutic  monitoring
• Monitoring  during  chemotherapy  is  generally  clinical
with  mammography  and  ultrasound  examinations.
Differential  diagnosis
• Infectious  mastitis  is  the  principle  differential
diagnosis  for  inﬂammatory  breast  cancer.
Differentiating  between  these  two  conditions
is  essentially  based  on  the  clinical  history  and
ultrasound.  Mammography  and  MRI  may  also  be
useful.
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• Post-therapeutic  and  particularly  post-radiation
lesions  may  be  the  cause  of  breast  inﬂammation.
Caution  is  nevertheless  needed  in  this  context.
• A  clear  distinction  must  be  made  between
inﬂammatory  breast  cancer  and  locally
advanced  cancer,  which  are  two  quite  distinct
clinicopathological  entities.
Clinical case
Mrs  I.  comes  to  see  you  for  a  breast  radiology  consultation
following  the  appearance  of  painful  erythema  of  the  right
breast.  She  is  a  42-year-old  patient  whose  history  includes
left  mastectomy  for  extensive  DCIS  at  35  years  of  age,  and  a
recent  T2N1  of  35  mm  of  the  right  sup.  lat.  quadrant  (grade
3  IDC,  RH-,  Her2-)  treated  by  neoadjuvant  chemotherapy
(4  FEC  100  +4  Taxotere)  then  conservative  surgery  and  axil-
lary  lymph  node  dissection.  The  tissue  removed  contained
2  cm  tumour  remains,  three  largely  invaded  lymph  nodes
and  two  cicatricial  lymph  nodes  (Sataloff  TC-NC).  Additional
a
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Figure 6. Right mammogram with MLO (a) and CC (b) incidence. Breas
and ultrasound of the right axilla (d).101
rradiation  of  the  breast  and  the  lymph  node  areas  was  per-
ormed  and  ﬁnished  three  months  ago.  The  erythema  has
ppeared  recently  and  is  accompanied  by  an  increase  in
reast  volume.
uestion 1
hat  would  you  do?  (Several  answers  are  possible):
. Clinical  examination;
.  Mammogram;
.  Ultrasound  examination;
.  MRI;
.  Nothing;
.  You  would  offer  her  an  onco-genetic  consultation  if  that
has  not  already  been  done.
nswer,  b  and  c.  Yes.  The  clinical  and  breast  ultrasound  exami-
ations  are  the  ﬁrst  examinations  to  perform  in  the  event
f  clinical  changes,  particularly  in  a  patient  who  has  under-
one  treatment.  Looking  for  an  intramammary  collection,
t ultrasound of the surgical zone of the right sup. lat. quadrant (c)
102  J.-P.  Alunni
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cigure 7. Bilateral breast MRI. Axial T2 TSE sequence (a). Dynam
or  example,  justiﬁes  these  examinations  and  the  ultrasound
hould  also  cover  the  lymph  node  areas.
d.  No,  not  as  a  ﬁrst  course  of  action,  all  the  more
o  because  the  irradiation  was  recent  and  could  cause
ost-radiation  phenomena  upsetting  reading  of  the  MRI.  In
ddition,  the  distinction  between  local  recurrence  and  post-
herapeutic  inﬂammatory  phenomena  can  be  difﬁcult.
e.  No.  The  possibility  of  very  early  local  recurrence,  par-
icularly  given  the  aggressiveness  of  the  initial  condition
nd  her  very  partial  response  to  the  chemotherapy,  justi-
es  performing  these  examinations  immediately.
f.  Yes,  even  if  it  is  not  the  best  of  times  to  choose.
lthough  this  patient  has  already  presented  a  bilateral  can-
er,  her  family  history  should  be  collected.
uestion 2
he  clinical  examination  indeed  reveals  inﬂammatory  signs
orange-peel  skin,  cutaneous  erythema,  increase  in  breast
olume  without  a  clearly  palpable  mass),  without  palpable
denopathy.  You  are  shown  the  mammograms  (Fig.  6a  and
)  and  a  breast  (Fig.  6c)  and  axillary  (Fig.  6d)  ultrasound
xamination  is  performed.  What  do  you  think?  (Several
nswers  are  possible):
a.  It  is  probably  a  post-therapeutic  phenomenon;
.  It  is  probably  recurrence  of  the  cancer  in  an  inﬂammatory
form;
c.  Biopsies  are  needed;
. You  offer  close  monitoring;
. You  perform  MRI.
nswer
.  Yes.  The  mammography  and  ultrasound  characteristics
the  absence  in  particular  of  a  mass,  and  a  ﬁne  surgical
car  and  benign  looking  axillary  lymph  nodes,  respectively)
upport  a  post-therapeutic  phenomenon,  and  very  early
ecurrence  is  rare.
b.  No.  There  are  no  speciﬁc  decisive  clinical  or
adiological  aspects.
c.  No.  Given  that  the  likelihood  of  recurrence  is  low,  it
s  possible  initially  to  defer  multiple  biopsies,  which  could
xacerbate  the  inﬂammatory  phenomena.
d.  Yes,  monitoring  could  be  proposed  in  the  ﬁrst  instance.
e.  No,  for  the  same  reasons  as  in  question  1.
R GE sequence with subtraction at 2 minutes (b).
uestion 3
fter  anti-inﬂammatory  treatment  and  local  care  arranged
ointly  with  the  oncologist,  the  clinical  situation  after  1
onth  is  stable.  An  MRI  is  performed  (Fig.  7).  What  do  you
hink?  (Several  answers  are  possible):
a.  The  diagnosis  of  post-radiation  inﬂammation  is  formally
conﬁrmed;
.  The  situation  remains  doubtful:  it  would  be  best  to  take
biopsies;
c.  The  MRI  was  useful;
.  The  MRI  was  not  useful.
nswer
.  No.  Post-radiation  phenomena  are  based  on  a  diagnosis  of
xclusion,  and  the  MRI  does  not  formally  exclude  evolving
ecurrence  even  if  the  absence  of  an  enhanced  intramam-
ary  mass  is  reassuring.  There  is  nevertheless  enhanced
kin  thickening  and  intramammary  oedema,  which  are  not
peciﬁc  to  any  aetiology.
b.  Yes,  histological  evidence  is  necessary.
c  and  d.  Yes  for  both  answers!  MRI  has  not  fundamen-
ally  changed  the  action  to  be  taken  and  biopsies  must  be
aken  despite  the  absence  in  this  examination  of  particu-
arly  suspect  characteristics.  However,  it  has  shown  the  lack
f  intramammary  uptake  of  contrast  and  consequently  the
kin  should  be  sampled.
The  skin  biopsies  are  ﬁnally  reassuring,  supporting
on-speciﬁc  inﬂammation,  without  carcinomatous  emboli.
linical  monitoring  is  continued  and  gradually  records
mprovement  in  the  inﬂammation.  The  condition  was  there-
ore  a  simple  post-radiation  phenomenon.
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